<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-QNA-C-CDF</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Scaling up HIV prevention, care and treatment services for Key Populations and People living with HIV in Kosovo, and Strengthening Tuberculosis (&quot;TB&quot;) control in Kosovo</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Kosovo - TB/HIV - Community Development Fund - CDF.  This program has the following goals: To maintain low prevalence of HIV among general population and key populations and improve the quality of life of people affected by AIDS in Kosovo.  To reduce the overall incidence of notified cases from 33.8  per 100,000 in 2019 to 23.6  per 100,000 in 2024 and maintain tuberculosis mortality in Kosovo below 1.5/100,000.. The objectives of this program are: Reduce the impact of HIV in general population and key populations by strengthening HIV prevention interventions and improve access to services.  Improve the health status and quality of life of people living with HIV by providing universal access to treatment, health care and other support services.  Ensure sustainable response to HIV through strengthening coordination, leadership and financial and political commitment of the Government.  Ensure sustainable response to HIV through resilient health systems strengthening interventions.  Empowerment and engagement of CSO in HIV policy, programming, advocacy and HIV services in the community through CSS.  Successfully treat all cases of tuberculosis and maintain at least 85% the treatment success rate..  Strengthen the early prevention and detection of tuberculosis by intensifying the active and passive findings of the cases by providing quality services and adequate measures of infection control and LTBI treatment of cases and other ongoing support..  Establish and support national-level policies and legal framework and ensure greater government political and financial commitment to effective TB response in Kosovo.  Improving patient-centred tuberculosis care through increased CSO engagement and strengthening public-private partnership.  Improve national capacity to investigate and assess the impact of tuberculosis control and pre-elimination of interventions.</narrative>
  </description>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">CCM Kosovo</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">CCM Kosovo</narrative>
  </participating-org>
  <participating-org role="3" type="15">
   <narrative xml:lang="EN">Community Development Fund</narrative>
  </participating-org>
  <participating-org role="4" type="15">
   <narrative xml:lang="EN">Community Development Fund</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="5046c2f5-21b8-48b9-94cf-b2188439f70d" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="QNA-C-CDF" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-01-20" type="1"></activity-date>
  <activity-date iso-date="2021-01-20" type="2"></activity-date>
  <activity-date iso-date="2024-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Natalia MANIC</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>natalia.manic@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Natalia MANIC</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>natalia.manic@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="XK" percentage="100">
   <narrative xml:lang="EN">Kosovo</narrative>
  </recipient-country>
  <sector code="13040" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">TB/HIV</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="2.24" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="B035C5CE-BA09-412B-B386-BB992AA6A20F" percentage="89.51" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Non-Pharmaceuticals (HPNP)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="1.6" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="2C35AA6C-5E80-4406-B78F-58398CFB1668" percentage="1.01" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Living support to client/ target population (LSCTP)</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="0.46" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="5.18" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2022-01-01">359464</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2022-01-01">18970</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2022-01-01">8106</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-01-01">1499</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2022-01-01">126054</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2022-01-01">1331</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2022-01-01">1518</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2022-01-01">1011</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="a81c9bc8-c51c-4ef8-b245-fd2e38ba2411">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-12-10"></transaction-date>
   <value currency="USD" value-date="2021-12-10">1799725.8</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QNA-C-CDF.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Community Development Fund</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="f185501a-3c53-40a4-b16a-ef3c293a3d9c">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-01-06"></transaction-date>
   <value currency="USD" value-date="2022-01-06">48907.18</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QNA-C-CDF.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Community Development Fund</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="08b68dcb-3005-4bde-81a5-a83573a20b62">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-01-06"></transaction-date>
   <value currency="USD" value-date="2022-01-06">717868.69</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QNA-C-CDF.</narrative>
   </description>
   <receiver-org type="15">
    <narrative xml:lang="EN">Community Development Fund</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for QNA-C-CDF</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 1517 Denominator: 5819 Percentage: 26.07</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 1683 Denominator: 6814 Percentage: 24.70</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 176 Denominator: 438 Percentage: 40.18</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 22 Denominator: 33 Percentage: 66.67</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 232 Denominator: 5037 Percentage: 4.61</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 33 Denominator: 89 Percentage: 37.08</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 419 Denominator: 6814 Percentage: 6.15</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 438</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 515 Denominator: 609 Percentage: 84.56</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 519 Denominator: 5819 Percentage: 8.92</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 73 Denominator: 5037 Percentage: 1.45</narrative>
     </comment>
    </baseline>
   </indicator>
  </result>
  <result aggregation-status="0" type="3">
   <title>
    <narrative xml:lang="EN">Impact indicator for QNA-C-CDF</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB mortality rate per 100,000 population</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 1.35</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 1.24</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 1.1</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-01-01"></period-start>
     <period-end iso-date="2024-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 1</narrative>
       <narrative xml:lang="EN">Target for: 2024</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people who inject drugs who are living with HIV</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Percentage: 0.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 0.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of sex workers who are living with HIV</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Percentage: 0.00</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 0.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of men who have sex with men who are living with HIV</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Percentage: 2.80</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 4.17</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Outcome indicator for QNA-C-CDF</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 24.57</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 27.3</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 25.4</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-01-01"></period-start>
     <period-end iso-date="2024-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 23.6</narrative>
       <narrative xml:lang="EN">Target for: 2024</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Treatment success rate of all forms of TB - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 515 Denominator: 609 Percentage: 84.56</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 86.00</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 87.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-01-01"></period-start>
     <period-end iso-date="2024-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 88.00</narrative>
       <narrative xml:lang="EN">Target for: 2024</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of men reporting the use of a condom the last time they had anal sex with a non regular partner</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Percentage: 46.40</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of sex workers reporting the use of a condom with their most recent client</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Percentage: 77.50</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 80.00</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of people who inject drugs reporting the use of sterile injecting equipment the last time they injected</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Percentage: 97.60</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 97.60</narrative>
       <narrative xml:lang="EN">Target for: 2023</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
